Removing Race Adjustment in Chronic Kidney Disease Care
A new study led by Stanford Health Policy researchers finds that algorithmic changes to a chronic kidney disease care equation are likely insufficient to achieve health equity as many other structural inequities remain.
QALY Ban Could Harm People with Disabilities and Chronic Illness
The U.S. House passed a bill that would ban the use of a metric known as quality-adjusted life-years (QALYs) in coverage and payment determinations for federal health-care programs. SHP's Joshua Salomon writes in this Health Affairs commentary the bill would compromise the evaluation of medical treatments.
In Conflict Zones and Borderlands, Paul Wise Protects the Health of Vulnerable Children
Stanford Health Policy's Paul Wise — professor of pediatrics and senior fellow at the Freeman Spogli Institute for International Studies — is featured in this Stanford Magazine story about his work at the U.S.-Mexico border as the federally appointed juvenile monitor and around the world as a pediatrician who works on behalf of children of conflict.
The U.S. House passed a bill that would ban the use of a metric known as quality-adjusted life-years (QALYs) in coverage and payment determinations for federal health-care programs. SHP's Joshua Salomon writes in this Health Affairs commentary the bill would compromise the evaluation of medical treatments.
In this Frontiers in Medicine flash talk, SHP's Joshua Salomon explains how the COVID-19 pandemic has exposed the urgent need to pair advances in scientific discovery with programs and policies that ensure all people can benefit from these breakthroughs.
Joshua Salomon and colleague Alyssa Bilinski write in this Health Affairs blog that there is an unmet need for a hybrid modeling approach: models that explore long-term questions, as in scenario models, but hew close to empirical data, as in forecasts.
SHP's Joshua Salomon and colleagues offer an alternative approach to COVID-19 vaccine distribution — modeling a flexible strategy that would result in an additional 23% to 29% of COVID-19 cases averted compared with the current fixed strategy,.
While there is no national, cohesive COVID-19 contact tracing plan, SHP's Joshua Salomon writes that it's important to continue to invest in contact tracing capacity now, because once we can get a handle on the virus, the combination of testing, contact tracing and supported isolation will be essential to the containment and outbreak response.
